P16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma

Modern Pathology

Volumn 25, Issue 11, 2012, Pages 1526-1533

  Alexander, Riley E ^a   Hu, Yingchuan ^a   Kum, Jennifer B ^a   Montironi, Rodolfo ^b   Lopez Beltran, Antonio ^c   MacLennan, Gregory T ^d   Idrees, Muhammad T ^a   Emerson, Robert E ^a   Ulbright, Thomas M ^a   Grignon, David G ^a   Eble, John N ^a   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

human papillomavirus; immunohistochemistry; in situ hybridization; p16; squamous cell carcinoma; urinary bladder

Indexed keywords

EID: 84868502370     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.103     Document Type: Article

References (40)

1. Lagwinski N, Thomas A, Stephenson AJ, et al. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol 2007; 31:1777-1787. (Pubitemid 350175805)
2. Kantor AF, Hartge P, Hoover RN, et al. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res 1988;48: 3853-3855.
3. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44:672-681. (Pubitemid 37542925)
4. Kassouf W, Spiess PE, Siefker-Radtke A, et al. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas MD Anderson Cancer Center experience. Cancer 2007;110:764-769. (Pubitemid 47257652)
5. Mostafa MH, Sheweita SA, O'Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999;12:97-111. (Pubitemid 29055955)
6. Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 2004;93:216-220.
7. Li N, Yang L, Zhang Y, et al. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis 2011;204:217-223.
8. Lopez-Beltran A, Escudero AL. Human papillomavirus and bladder cancer. Biomed Pharmacother 1997;51: 252-257. (Pubitemid 27296836)
9. Shigehara K, Sasagawa T, Kawaguchi S, et al. Etiologic role of human papillomavirus infection in bladder carcinoma. Cancer 2011;117:2067-2076.
10. Boucher NR, Anderson JB. Human papillomavirus and bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct 1997;8:354-357. (Pubitemid 28203927)
11. Boucher NR, Scholefield JH, Anderson JB. The aetiological significance of human papillomavirus in bladder cancer. Br J Urol 1996;78:866-869. (Pubitemid 27407787)
12. Youshya S, Purdie K, Breuer J, et al. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol 2005;58:207-210. (Pubitemid 40193809)
13. Agoff SN, Lin P, Morihara J, et al. P16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003;16:665-673. (Pubitemid 36871499)
14. Benevolo M, Mottolese M, Marandino F, et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006;19:384-391. (Pubitemid 43276992)
15. Dehn D, Torkko KC, Shroyer KR. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 2007;111:1-14. (Pubitemid 46281079)
16. Doxtader EE, Katzenstein AL. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum Pathol 2012;43:327-332.
17. Horn LC, Lindner K, Szepankiewicz G, et al. P16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix. Int J Gynecol Pathol 2006;25:182-186. (Pubitemid 44620183)
18. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-891. (Pubitemid 32594981)
19. Klaes R, Benner A, Friedrich T, et al. P16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399. (Pubitemid 35239415)
20. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284. (Pubitemid 32225381)
21. Kong CS, Balzer BL, Troxell ML, et al. P16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007;31:33-43. (Pubitemid 46036900)
22. Negri G, Egarter-Vigl E, Kasal A, et al. P16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003;27:187-193. (Pubitemid 36152227)
23. Nieh S, Chen SF, Chu TY, et al. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 2005;97:35-40. (Pubitemid 40403671)
24. Pientong C, Ekalaksananan T, Kongyingyoes B, et al. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection. Diagn Cytopathol 2004;31:235-242. (Pubitemid 39314818)
25. Samarawardana P, Dehn DL, Singh M, et al. P16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia. Cancer Cytopathol 2010;118:146-156.
26. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009;35: 210-220.
27. Wang JL, Zheng BY, Li XD, et al. P16INK4A and p14ARF expression pattern by immunohistochemistry in human papillomavirus-related cervical neoplasia. Mod Pathol 2005;18:629-637.
28. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-527. (Pubitemid 36159887)
29. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994; 186:131-156. (Pubitemid 24099089)
30. Subhawong AP, Subhawong T, Nassar H, et al. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol 2009;33:163-175.
31. Cheng L, Leibovich BC, Cheville JC, et al. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 2000;88:1679-1686. (Pubitemid 30183154)
32. Chaux A, Pfannl R, Lloveras B, et al. Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature. Am J Surg Pathol 2010;34:385-392.
33. Cubilla AL, Lloveras B, Alejo M, et al. Value of p16(INK)(a) in the pathology of invasive penile squamous cell carcinomas: a report of 202 cases. Am J Surg Pathol 2011;35:253-261.
34. Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, et al. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis 2005;5:102.
35. Shigehara K, Sasagawa T, Doorbar J, et al. Etiological role of human papillomavirus infection for inverted papilloma of the bladder. J Med Virol 2011;83:277-285.
36. Moonen PM, Bakkers JM, Kiemeney LA, et al. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-468.
37. Cai T, Mazzoli S, Meacci F, et al. Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study. Oncol Rep 2011;25:485-489.
38. Guo CC, Gomez E, Tamboli P, et al. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol 2009;40:1448-1452.
39. Westenend PJ, Stoop JA, Hendriks JG. Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder. BJU Int 2001;88:198-201. (Pubitemid 32863037)
40. Ben Selma W, Ziadi S, Ben Gacem R, et al. Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients. Pathol Res Pract 2010;206: 740-743.